WallStreetZenWallStreetZen

NASDAQ: OTLK
Outlook Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Outlook Therapeutics revenue was $1.41M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2025) ending on Sep 30, 2025 was -$91.8k, down 106.1% from last quarter. For the last reported fiscal year 2025 ending Sep 30, 2025, OTLK annual revenue was $1.4M, with Infinity% growth year-over-year.

OTLK revenue history

Current Revenue
$1.4M
Current Earnings
-$62.4M
Current Profit Margin
-4,416.2%

Be the first to know when OTLK announces revenue.

OTLK Revenue History By Year

OTLK Yearly RevenueOTLK RevenueOTLK ChangeOTLK Revenue Growth
2025-09-30$1.41MN/AN/A
2024-09-30$0.00N/AN/A
2023-09-30$0.00N/AN/A
2022-09-30$0.00N/AN/A
2021-09-30$0.00N/AN/A
2020-09-30$0.00-$8.15M-100.00%
2019-09-30$8.15M$5.06M+163.84%
2018-09-30$3.09M-$723.96k-18.99%
2017-09-30$3.81M$831.94k+27.92%
2016-09-30$2.98M-$2.24M-42.91%
2015-09-30$5.22M-$3.83M-42.33%
2014-09-30$9.05MN/AN/A

1 of 1

Outlook Therapeutics Revenue FAQ

What was OTLK's revenue last quarter?

Outlook Therapeutics (NASDAQ: OTLK) reported Q3 2025 revenue of -$91.79 thousand up Infinity% year over year. In the same quarter last year, Outlook Therapeutics's revenue was $0.00.

What was Outlook Therapeutics's revenue in 2025?

Outlook Therapeutics's annual revenue for the twelve months ending Sep 30, 2025 was $1.41 million, a Infinity% increase year over year.

How much does Outlook Therapeutics make in a day?

Based on Outlook Therapeutics annual revenue for the past five years, OTLK makes an average of $774.54 per day.

What was Outlook Therapeutics's annual revenue growth in the past year?

As of Q1 2026, Outlook Therapeutics's revenue has grown null year over year. Outlook Therapeutics's revenue in the past year totaled $1.41 million.

How much does Outlook Therapeutics make in a year?

Outlook Therapeutics's revenue by year for the past five years is:
  • Outlook Therapeutics's revenue for the twelve months ending Sep 30, 2025 was $1.41 million, a Infinity% increase year over year.
  • Outlook Therapeutics's annual revenue for Sep 30, 2024 was $0.00, a N/A decrease from 2023.
  • Outlook Therapeutics's annual revenue for 2023 was $0.00, a N/A decrease from 2022.
  • Outlook Therapeutics's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
  • Outlook Therapeutics's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.